Skip to Main Content

Paper Details

Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.
Cancer Commun (Lond)
15
2021
DLBCL, Diffuse large B-cell lymphoma, Patients, central nervous system relapse, diffuse large B-cell lymphoma, patients, rituximab, stem-cell
Author NameAffiliation
Chung-Chou H ChangGraduate School of Public Health, University of Pittsburgh
Yao LiuXinqiao Hospital, Army Medical University
  • 1 - 2

Datasets

Release 1.2